Hormone replacement therapy (HRT) is worth considering if menopause symptoms are disrupting your daily life, you’re under 60 or within 10 years of menopause onset, and you don’t have specific medical conditions that make it unsafe. That’s the short answer, but the real decision involves weighing your symptoms, your health history, and how you’d prefer to take treatment. Here’s what goes into that calculus.
The Symptoms HRT Actually Treats
HRT is FDA-approved for four specific problems: hot flashes, night sweats, vaginal dryness, and painful sex. It also reduces the chances of developing osteoporosis. If your main complaints fall outside this list, such as brain fog, joint pain, or weight gain, HRT may or may not help, and the evidence is less clear.
The key question isn’t whether you have these symptoms but whether they’re bothersome enough to affect your quality of life. Night sweats that wake you up regularly, hot flashes that interrupt work or social situations, or vaginal dryness that makes sex painful are all strong reasons to talk with a doctor about HRT. If your symptoms are mild and manageable with lifestyle changes, the risk-benefit math shifts.
The Timing Window Matters
When you start HRT relative to menopause onset is one of the most important factors. For women under 60 or within 10 years of menopause, the benefits generally outweigh the risks. This is sometimes called the “window of opportunity,” and it applies to both symptom relief and cardiovascular health.
Women who start HRT within this window show trends toward reduced coronary heart disease. In reanalysis of a major clinical trial, women who began estrogen-only therapy within 10 years of menopause had a hazard ratio of 0.59 for coronary heart disease, meaning their risk was roughly 40% lower than those on placebo. For women starting HRT more than 20 years after menopause or at age 70 and older, the picture reverses: cardiovascular risk increases. HRT should not be started in women over 60 or more than a decade past menopause for heart protection purposes.
Health Conditions That Rule It Out
Certain medical histories make HRT unsuitable. You should tell your doctor before considering it if you have ever had breast cancer, are being evaluated for breast cancer, or are considered high risk due to family history. The same applies if you’ve had a cancer that responds to estrogen, such as endometrial cancer.
A history of blood clots is another major concern. This includes deep vein thrombosis in the legs, pulmonary embolism, or conditions caused by arterial clots like heart attack, stroke, or angina. Active or recent liver disease with abnormal liver function also rules out standard HRT. If none of these apply to you, you’re likely in the eligible category, though your doctor will consider your full health picture.
You Probably Don’t Need Hormone Testing First
Many women assume they need blood work to check hormone levels before starting HRT. The American College of Obstetricians and Gynecologists says otherwise: hormone testing isn’t recommended before starting therapy for menopausal symptoms. Hormone levels fluctuate so much during the menopause transition that a single test rarely provides useful information. Your doctor should be able to recommend HRT based on your symptoms, menstrual changes, and medical history alone.
You will, however, need to be up to date on routine screenings like mammograms, and your doctor will review your personal and family medical history in detail before prescribing.
Estrogen-Only vs. Combined Therapy
Which type of HRT you’d take depends largely on whether you still have your uterus. Women who’ve had a full hysterectomy typically use estrogen-only therapy, starting at a low dose and adjusting as needed. Women with an intact uterus need combined therapy, meaning estrogen plus a progestogen, because estrogen alone can cause the uterine lining to thicken abnormally, raising the risk of endometrial cancer.
This distinction matters for the risk conversation too. A large international meta-analysis found that combined estrogen-progestogen therapy carries a higher breast cancer risk than estrogen-only therapy. Over five years of use starting at age 50, roughly 1 in 50 women using estrogen plus daily progestogen would develop breast cancer that wouldn’t have occurred otherwise. For estrogen-only therapy, that number drops to about 1 in 200. Ten years of use roughly doubles these figures. The risk increases steadily with duration, and it’s present even in the first four years of use, though smaller.
This doesn’t mean combined therapy is too dangerous to consider. It means the decision depends on how severe your symptoms are, how long you plan to use HRT, and what your baseline breast cancer risk looks like.
Patches and Gels vs. Pills
HRT comes in several forms: pills, skin patches, gels, and vaginal preparations. The choice isn’t just about convenience. Transdermal options (patches and gels) have a meaningfully different safety profile from oral pills when it comes to blood clots.
A meta-analysis found that oral HRT raised the risk of venous blood clots by about 2.5 times compared to nonusers, while transdermal HRT showed no statistically significant increase (1.2 times, with the confidence interval crossing 1.0). The reason: estrogen absorbed through the skin bypasses the liver, avoiding the increase in clotting factors that oral estrogen triggers. For women who carry genetic mutations that predispose them to clotting, the difference is stark. Oral HRT increased their clot risk 25-fold compared to nonusers, while transdermal estrogen raised it about fourfold.
If you have any history of clotting risk, even obesity or immobility, transdermal delivery is the preferred route. For breast cancer and cardiovascular outcomes, current research hasn’t found a meaningful difference between the two delivery methods.
What to Expect After Starting
Most women notice improvement within a few weeks. Hot flashes ease, sleep quality improves, and mood stabilizes. Some people feel changes within days, while others need a few months. If you’ve been on HRT for several months without noticeable relief, your doctor can adjust the dose, switch the type of hormone, or refer you to a menopause specialist.
For bone health, the benefits accumulate over time. HRT reduces the risk of vertebral fractures by about 40%, hip fractures by 30%, and all osteoporotic fractures by 20 to 30% compared to calcium and vitamin D alone. These protective effects last as long as you continue treatment.
Making the Decision
There’s no single test or checklist that tells you HRT is right for you. The decision comes down to a handful of practical questions: Are your symptoms significantly affecting your quality of life? Are you within the timing window (under 60 or within 10 years of menopause)? Do you have any of the medical conditions that make HRT unsafe? And are you comfortable with the level of risk, particularly for breast cancer, given how long you’d plan to use it?
If your symptoms are primarily vaginal (dryness, painful sex), low-dose vaginal estrogen is an option that carries minimal systemic risk, and the large meta-analysis on breast cancer found no increased risk with vaginal estrogen specifically. This can be a good starting point for women who are hesitant about systemic therapy.
For women with moderate to severe hot flashes and night sweats who fall within the safe timing window and have no contraindications, HRT remains the most effective treatment available. The conversation with your doctor should focus not on whether HRT works, but on which formulation, delivery method, and duration best fit your body and your risk profile.